Zajicek J
Department of Neurology, Derriford Hospital, Plymouth.
Br J Hosp Med. 1997;57(4):137-40.
The management of multiple sclerosis (MS) is changing, and for the first time treatments which appear to influence the course of the disease are becoming available. This article examines our current understanding of MS pathogenesis and assesses which, if any, of the emerging therapies are likely to make an impact on this potentially disabling condition.
多发性硬化症(MS)的治疗方法正在发生变化,首次有了似乎能影响该病病程的治疗手段。本文探讨了我们目前对MS发病机制的理解,并评估了哪些新兴疗法(如果有的话)可能对这种潜在致残性疾病产生影响。